Reuters logo
BRIEF-Aquinox Pharmaceuticals says Q1 loss per share $0.36
May 9, 2017 / 10:28 AM / 4 months ago

BRIEF-Aquinox Pharmaceuticals says Q1 loss per share $0.36

May 9 (Reuters) - Aquinox Pharmaceuticals Inc:

* Says Q1 net loss $8.3 million

* Aquinox Pharmaceuticals says plans to provide guidance on top line data availability from leadership 301 trial in early August

* Says top line data from leadership 301 trial is anticipated in 2018

* Q1 loss per share $0.36 Source text:(bit.ly/2pZqDtp) Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below